A machine learning model to predict whether patients with rheumatoid arthritis will respond to TNF inhibitors has been produced following an international crowd-sourced competition, but is the mixture of clinical and omics biomarkers used in this model optimal for clinical use?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multi-omics approach to precision medicine for immune-mediated diseases
Inflammation and Regeneration Open Access 01 August 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hunter, T. M. et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol. Int. 37, 1551–1557 (2017).
Guan, Y. et al. Machine learning to predict anti-TNF drug responses of rheumatoid arthritis patients by integrating clinical and genetic markers. Arthritis Rheumatol. https://doi.org/10.1002/art.41056 (2019).
Massey, J. et al. Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis. Pharmacogenom. J. 18, 657–664 (2018).
Spiliopoulou, A. et al. Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. Ann. Rheum. Dis. 78, 1055–1061 (2019).
Plant, D. et al. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis. Arthritis Rheumatol. 68, 1353–1360 (2016).
Sieberts, S. K. et al. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat. Commun. 7, 12460 (2016).
Plenge, R. M. et al. Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nat. Genet. 45, 468–469 (2013).
Kremer, J. The CORRONA database. Ann. Rheum. Dis. 64 (Suppl. 4), iv37–41 (2005).
Hensor, E. M. A. et al. Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis. Rheumatology 58, 1400–1409 (2019).
Rao, A. S. & Knowles, J. W. Polygenic risk scores in coronary artery disease. Curr. Opin. Cardiol. 34, 435–440 (2019).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Nair, N., Wilson, A.G. Can machine learning predict responses to TNF inhibitors?. Nat Rev Rheumatol 15, 702–704 (2019). https://doi.org/10.1038/s41584-019-0320-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-019-0320-9
This article is cited by
-
Multi-omics approach to precision medicine for immune-mediated diseases
Inflammation and Regeneration (2021)
-
An introduction to machine learning and analysis of its use in rheumatic diseases
Nature Reviews Rheumatology (2021)
-
Small-molecule inhibitors get pro-inflammatory TNF into shape
Nature Reviews Rheumatology (2020)